XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.20.2

Investments in Other Entities — Equity Method (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract] |
Equity Method Investments | Rollforward of Equity Method Investment (in thousands)
| December 31, 2019 |  | Allocation of Income (Loss) |  | Contribution |  | Sale |  | September 30, 2020
LaSalle Medical Associates – IPA Line of Business | $ | 6,397 |  |  | $ | 28 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,425 |
Pacific Medical Imaging & Oncology Center, Inc. | 1,396 |  |  | 25 |  |  | — |  |  | — |  |  | 1,421 |
Universal Care, Inc. | 1,438 |  |  | 3,560 |  |  | — |  |  | (4,998) |  |  | — |
Diagnostic Medical Group | 2,334 |  |  | 19 |  |  | — |  |  | — |  |  | 2,353 |
531 W. College, LLC – related party | 16,698 |  |  | (351) |  |  | 500 |  |  | — |  |  | 16,847 |
MWN, LLC – related party | 164 |  |  | 10 |  |  | — |  |  | — |  |  | 174 |
| $ | 28,427 |  |  | $ | 3,291 |  |  | $ | 500 |  |  | $ | (4,998) |  |  | $ | 27,220 |
LMA’s summarized balance sheets at September 30, 2020 and December 31, 2019, and summarized statements of operations for the nine months ended September 30, 2020 and 2019, with respect to its IPA line of business are as follows (in thousands): Balance Sheets
| September 30, 2020 |  | December 31, 2019
Assets |  |  |
Cash and cash equivalents | $ | 3,794 |  |  | $ | 6,345 |
Receivables, net | 6,782 |  |  | 5,124 |
Other current assets | 880 |  |  | 3,526 |
Loan receivable | 2,250 |  |  | 2,250 |
Restricted cash | 690 |  |  | 683 |
Total assets | $ | 14,396 |  |  | $ | 17,928 |
Liabilities and Stockholders’ Deficit |  |  |
Current liabilities | $ | 19,886 |  |  | $ | 23,530 |
Stockholders’ deficit | (5,490) |  |  | (5,602) |
Total liabilities and stockholders’ deficit | $ | 14,396 |  |  | $ | 17,928 |
Statements of Operations
| Nine Months Ended September 30,
| 2020 |  | 2019
Revenues | $ | 138,490 |  |  | $ | 144,570 |
Expenses | 138,233 |  |  | 155,582 |
Net income (loss) | $ | 257 |  |  | $ | (11,012) |
UCI's balance sheet at December 31, 2019 and statements of income for the four months ended April 30, 2020 and nine months ended September 30, 2019 are as follows (in thousands): Balance Sheets
| December 31, 2019
Assets |
Cash and cash equivalents | $ | 33,890 |
Receivables, net | 63,843 |
Other current assets | 38,280 |
Loan receivable | 882 |
Restricted cash | 4,021 |
Total assets | $ | 140,916 |
Liabilities and Stockholders’ Deficit |
Current liabilities | $ | 128,330 |
Other liabilities | 33,133 |
Stockholders’ deficit | (20,547) |
Total liabilities and stockholders’ deficit | $ | 140,916 |
Statements of Operations
| Four Months Ended April 30, 2020 |  | Nine Months Ended September 30, 2019
Revenues | $ | 195,308 |  |  | $ | 372,181 |
Expenses | 189,028 |  |  | 370,597 |
Income before benefit from income taxes | 6,280 |  |  | 1,584 |
Benefit from income taxes | — |  |  | (11,010) |
Net income | $ | 6,280 |  |  | $ | 12,594 |
531 W. College LLC’s balance sheets at September 30, 2020 and December 31, 2019, and statements of operations for the nine months ended September 30, 2020 and 2019, are as follows (in thousands): Balance sheets
| September 30, 2020 |  | December 31, 2019
Assets |  |  |
Cash | $ | 8 |  |  | $ | 139 |
Other current assets | 25 |  |  | 17 |
Other assets | 70 |  |  | 70 |
Property and equipment, net | 33,697 |  |  | 33,581 |
Total assets | $ | 33,800 |  |  | $ | 33,807 |
Liabilities and Members’ Equity |  |  |
Current liabilities | $ | 1,257 |  |  | $ | 1,062 |
Stockholders’ equity | 32,543 |  |  | 32,745 |
Total liabilities and members’ equity | $ | 33,800 |  |  | $ | 33,807 |
Statements of Operation
| Nine Months Ended September 30,
| 2020 |  | 2019
Revenues | $ | — |  |  | $ | — |
Expenses | 828 |  |  | 780 |
Loss from operations | (828) |  |  | (780) |
Other income | 32 |  |  | 427 |
Provision for income tax | 3 |  |  | — |
Net loss | $ | (799) |  |  | $ | (353) |
Equity Method Investment, Gain On Sale | The gain on sale of equity method investment recognized in connection with this transaction was determined as follows (in thousands):
| Amount
Cash proceeds (excludes proceeds to settle indebtedness owed to APC from UCI) | $ | 52,743 |
Preferred shares in Bright Health, Inc. | 36,179 |
Beneficial interest in UCI | 15,723 |
Less: Carrying value of equity method investment on date of sale | (4,998) |
Gain on sale of equity method investment | $ | 99,647 |

X
- Definition Equity Method Investment, Gain On Sale + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentGainOnSaleTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration